Literature DB >> 16251331

High prevalence of glycopeptide resistance genes vanB, vanD, and vanG not associated with enterococci in human fecal flora.

M-C Domingo1, A Huletsky, R Giroux, K Boissinot, F J Picard, P Lebel, M J Ferraro, M G Bergeron.   

Abstract

The presence of Enterococcus-associated vancomycin resistance genes vanA, vanB, vanD, vanE, and vanG in rectal swabs was investigated in two hospitals using PCR. All vanA genes detected were associated with vancomycin-resistant enterococci (VRE), whereas VRE-associated vanB genes were detected in only one hospital (4.7%). However, in both hospitals, high prevalences of vanB (6.2 and 2.3%), vanD (43.8 and 26.7%), and vanG (10.5 and 6.9%) genes not associated with enterococci were found.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16251331      PMCID： PMC1280134          DOI： 10.1128/AAC.49.11.4784-4786.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

1.  Enterococcal vanB resistance locus in anaerobic bacteria in human faeces.

Authors:  T P Stinear; D C Olden; P D Johnson; J K Davies; M L Grayson
Journal:  Lancet       Date:  2001-03-17       Impact factor: 79.321

2.  Development of conventional and real-time PCR assays for the rapid detection of group B streptococci.

Authors:  D Ke; C Ménard; F J Picard; M Boissinot; M Ouellette; P H Roy; M G Bergeron
Journal:  Clin Chem       Date:  2000-03       Impact factor: 8.327

3.  Comparison of three PCR primer sets for identification of vanB gene carriage in feces and correlation with carriage of vancomycin-resistant enterococci: interference by vanB-containing anaerobic bacilli.

Authors:  S A Ballard; E A Grabsch; P D R Johnson; M L Grayson
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 4.  Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci.

Authors:  N Woodford
Journal:  Microb Drug Resist       Date:  2001       Impact factor: 3.431

5.  Characterization of a Tn5382-like transposon containing the vanB2 gene cluster in a Clostridium strain isolated from human faeces.

Authors:  M-C Domingo; A Huletsky; A Bernal; R Giroux; D K Boudreau; F J Picard; M G Bergeron
Journal:  J Antimicrob Chemother       Date:  2005-02-24       Impact factor: 5.790

6.  Molecular characterization of vanB elements in naturally occurring gut anaerobes.

Authors:  S A Ballard; K K Pertile; M Lim; P D R Johnson; M L Grayson
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

Review 7.  Clinical impact of vancomycin-resistant enterococci.

Authors:  Robin Patel
Journal:  J Antimicrob Chemother       Date:  2003-06       Impact factor: 5.790
  7 in total
  19 in total

1.  Identification of a Novel Genomic Island Associated with vanD-Type Vancomycin Resistance in Six Dutch Vancomycin-Resistant Enterococcus faecium Isolates.

Authors:  Janetta Top; Jan C Sinnige; Ellen C Brouwer; Guido Werner; Jukka Corander; Juliëtte A Severin; Rogier Jansen; E Bathoorn; Marc J M Bonten; John W A Rossen; Rob J L Willems
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  VanG-type vancomycin-resistant Enterococcus faecalis strains isolated in Canada.

Authors:  David A Boyd; Tim Du; Romeo Hizon; Brynn Kaplen; Travis Murphy; Shaun Tyler; Shirley Brown; Frances Jamieson; Karl Weiss; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

Review 3.  Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species.

Authors:  Surbhi Malhotra-Kumar; Kelly Haccuria; Mindy Michiels; Margareta Ieven; Claire Poyart; Waleria Hryniewicz; Herman Goossens
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

4.  Evaluation of the novel artus C. difficile QS-RGQ, VanR QS-RGQ and MRSA/SA QS-RGQ assays for the laboratory diagnosis of Clostridium difficile infection (CDI), and for vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) screening.

Authors:  K A Morris; L R Macfarlane-Smith; M H Wilcox
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-16       Impact factor: 3.267

5.  ICESluvan, a 94-kilobase mosaic integrative conjugative element conferring interspecies transfer of VanB-type glycopeptide resistance, a novel bacitracin resistance locus, and a toxin-antitoxin stabilization system.

Authors:  Eva K Bjørkeng; Erik Hjerde; Torunn Pedersen; Arnfinn Sundsfjord; Kristin Hegstad
Journal:  J Bacteriol       Date:  2013-09-27       Impact factor: 3.490

6.  Clostridium clostridioforme and Atopobium minutum clinical isolates with vanB-type resistance in France.

Authors:  Jean-Christophe Marvaud; Francine Mory; Thierry Lambert
Journal:  J Clin Microbiol       Date:  2011-07-20       Impact factor: 5.948

Review 7.  Acquired inducible antimicrobial resistance in Gram-positive bacteria.

Authors:  Scott T Chancey; Dorothea Zähner; David S Stephens
Journal:  Future Microbiol       Date:  2012-08       Impact factor: 3.165

8.  vanD and vanG-like gene clusters in a Ruminococcus species isolated from human bowel flora.

Authors:  M-C Domingo; A Huletsky; R Giroux; F J Picard; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

Review 9.  Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care Setting.

Authors:  Matthew L Faron; Nathan A Ledeboer; Blake W Buchan
Journal:  J Clin Microbiol       Date:  2016-05-04       Impact factor: 5.948

10.  Comparison of the BD GeneOhm VanR assay to culture for identification of vancomycin-resistant enterococci in rectal and stool specimens.

Authors:  Paul D Stamper; Mian Cai; Clara Lema; Kim Eskey; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2007-08-17       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.